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Sir,
I read with interest the article of Coventry and Morton
(2003) that investigated DC infiltration within breast cancers
and the association with survival. Interestingly, they found
that more patients were alive at the 5-year time point in the
group with higher CD1a DC density than the lower CD1a DC
group, but this failed to reach statistical significance at the P¼0.05
level.
In our opinion, the role of CD1 family molecules in antitumour
immune responses, and in particular of CD1a, should be more
debated, since its expression was recently described not only in
monocyte-derived dendritic cells, but also in nonmesenchymal
cytotypes, that is, epithelial cells (Ulanova et al, 2000).
We recently described the immunoexpression of CD1a by
metaplastic cells in a large series of Barrett’s metaplasia, both
gastric- and intestinal-type (Cappello et al, 2003); we found a
strong expression of this marker in epithelial cells of metaplastic
glands, whereas normal gastric and colonic mucosae resulted
negative. This expression had a diagnostic role, as well as predict a
favourable outcome, since its expression lacked when, at follow-
up, the same metaplastic lesions progressed towards dysplasia or
cancer.
Based on all these observations, we strongly recommend further
studies on the antitumour role of CD1a and its potential role
during immuno-surveillance, not only in invasive cancers but also
during the carcinogenetic steps.
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